Stay updated on HER2/EGFR Mutant Tumors Clinical Trial
Sign up to get notified when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.

Latest updates to the HER2/EGFR Mutant Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe record history now lists Revision: v3.6.4 as the latest entry and removes Revision: v3.6.3, reflecting a small maintenance update to the history log.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.6.3 was added to the history and Revision: v3.6.2 was removed, representing a small software version update to the page’s underlying system.SummaryDifference0.0%

- Check36 days agoChange DetectedA new revision entry (v3.6.2) was added to the page history, replacing the previous v3.6.0 entry. This indicates a minor update to the page's revision notes.SummaryDifference0.0%

- Check50 days agoChange DetectedThe study history now indicates enrollment is closed, and the record version has been updated to v3.6.0 (removing the prior v3.5.5).SummaryDifference0.3%

- Check57 days agoChange DetectedThe footer's revision tag was updated to v3.5.5, replacing the previous v3.5.4.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page footer revision label has been updated from v3.5.3 to v3.5.4, indicating a minor version update.SummaryDifference0.0%

Stay in the know with updates to HER2/EGFR Mutant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.